Lord, Abbett & Co. LLC Adma Biologics, Inc. Transaction History
Lord, Abbett & Co. LLC
- $30.7 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 3,094,457 shares of ADMA stock, worth $62.5 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,094,457Holding current value
$62.5 Million% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
315Shares Held
184MCall Options Held
864KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$377 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$366 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$263 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$255 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$174 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.97B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...